Quality-of-life outcomes after primary androgen deprivation therapy: Results from the Prostate Cancer Outcomes Study

Journal of Clinical Oncology

Volumn 19, Issue 17, 2001, Pages 3750-3757

  Potosky, A L ^a   Knopf, K ^a   Clegg, L X ^a   Albertsen, P C ^a   Stanford, J L ^a   Hamilton, A S ^a   Gilliland, F D ^a   Eley, J W ^a   Stephenson, R A ^a   Hoffman, R M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GONADORELIN AGONIST;

ADULT; AGED; ANXIETY; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; GYNECOMASTIA; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SEXUAL FUNCTION; TREATMENT OUTCOME;

EID: 0035449137     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.17.3750     Document Type: Article

References (23)

1. Hormone therapy for prostate cancer: Results of the Veterans Administration Cooperative Urological Research Group studies
2. Hormonal therapy for locally advanced prostate cancer
3. The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogue
4. Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis
5. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer
6. Combined androgen blockade for the treatment of metastatic cancer of the prostate
7. Maximal ardrogen blockade for advanced prostate cancer
8. A new look at an old option in the treatment of early-stage prostate cancer: Hormone therapy as an alternative to watchful waiting
9. Practice trends in the diagnosis and management of prostate cancer in the United States
10. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy
11. Quality of life and psychosocial status in stage D prostate cancer: Zoladex Prostate Cancer Study Group
12. Health-related quality of life among patients with metastatic prostate cancer
13. Quality-of-life outcomes in long-term survivors of advanced prostate cancer
14. Prostate cancer practice patterns and quality of life: The Prostate Cancer Outcomes study
15. Patient-reported complications and follow-up treatment following radical prostatectomy: The national Medicare experience (1988-1990)
16. Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study
17. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure
18. Validation study of retrospective recall of disease-targeted function
19. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups
20. Cost comparison of orchiectomy and leuprolide in metastatic prostate cancer
21. Cost-effectiveness of androgren suppression therapies in advanced prostate cancer
22. Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial